MARGARET CARPINO: Open Payments
NPI 1811164759 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$390 in 15 payments from 7 companies in 2025. Trend: 2023 $227 · 2024 $444 · 2025 $390
Food & beverage: $296Education: $94
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $172 |
| PFIZER INC. | 4 | $105 |
| Novo Nordisk Inc | 2 | $33 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Celltrion USA Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: TREMFYA, XELJANZ, VELSIPITY, Wegovy, REZDIFFRA, VEGZELMA, ZEPBOUND.
Industry payments across MD — which companies pay providers there.
